VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Therapeutic Proteins

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 22 out of 100

  • Biotech & therapeutics
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

TPI focused on making biosimilar medications affordable by developing a proprietary, single-use technology platform, MayaBio®, to build a strong pipeline of biosimilar candidates. TPI renamed to Adello Biologics in 2016 and was acquired by Kashiv BioSciences in 2019.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy